Evidence map›Paper›PMID 36136329›Full record

SynthesisJAMA network open2022

Prognostic Implications of Fractional Flow Reserve After Coronary Stenting: A Systematic Review and Meta-analysis.

Doyeon Hwang, Bon-Kwon Koo, Jinlong Zhang, Jiesuck Park, Seokhun Yang, Minsang Kim, Jun Pil Yun, Joo Myung Lee, Chang-Wook Nam, Eun-Seok Shin and 23 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Clinical Impact of Concordant and Discordant Physiology Parameters Post-Percutaneous Coronary Intervention in the EASY-PREDICT Study.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Trial
  5. Trial
  6. Article
  7. Article
  8. Effectiveness and clinical impact of functional post-PCI optimization-a systematic review and individual patient-data meta-analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Sex Differences in Atherosclerotic Coronary Artery Disease Patterns.Journal of the American Heart Association · 2025
    Article
  15. Impact of an interactive CTCA/FFRThe international journal of cardiovascular imaging · 2025
    Article
  16. Article
  17. Impact of Post Percutaneous Coronary Intervention Fractional Flow Reserve on 5-Year Clinical Outcomes (The FFR SEARCH Study).Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Observational
  18. Observational
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Doyeon HwangDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Bon-Kwon KooDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Jinlong ZhangDepartment of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Jiesuck ParkDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Seokhun YangDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Minsang KimDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Jun Pil YunDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Joo Myung LeeDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Chang-Wook NamDepartment of Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.
Eun-Seok ShinDivision of Cardiology, Ulsan Hospital, Ulsan, Korea.
Joon-Hyung DohDepartment of Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.
Shao-Liang ChenDivision of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Tsunekazu KakutaDivision of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
Gabor G TothUniversity Heart Centre Graz, Medical University Graz, Austria.
Zsolt PirothGottsegen Hungarian Institute of Cardiology, Budapest, Hungary.
Nils P JohnsonWeatherhead PET Center For Preventing and Reversing Atherosclerosis, Division of Cardiology, Department of Medicine, University of Texas Medical School and Memorial Hermann Hospital, Houston.
Nico H J PijlsDepartment of Cardiology, Catharina Hospital, Eindhoven, the Netherlands.
Abdul HakeemDivision of Cardiovascular Diseases & Hypertension, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey.
Barry F UretskyCentral Arkansas VA Health System, Little Rock, Arkansas.
Yohei HokamaDepartment of Cardiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
Nobuhiro TanakaDepartment of Cardiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
Hong-Seok LimDepartment of Cardiology, Ajou University School of Medicine, Suwon, Korea.
Tsuyoshi ItoDepartment of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Akiko MatsuoDepartment of Cardiology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Lorenzo AzzaliniDivision of Cardiology, Department of Medicine, University of Washington, Seattle.
Massoud A LeesarDivision of Cardiovascular Diseases, University of Alabama, Birmingham.
Tara NelemanDepartment of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Nicolas M van MieghemDepartment of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Roberto DilettiDepartment of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Joost DaemenDepartment of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Damien CollisonWest of Scotland Regional Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom.
Carlos ColletCardiovascular Center Aalst, Aalst, Belgium.
Bernard De BruyneCardiovascular Center Aalst, Aalst, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Fractional flow reserve (FFR) after percutaneous coronary intervention (PCI) is generally considered to reflect residual disease. Yet the clinical relevance of post-PCI FFR after drug-eluting stent (DES) implantation remains unclear. Objective: To evaluate the clinical relevance of post-PCI FFR measurement after DES implantation. Data Sources: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched for relevant published articles from inception to June 18, 2022. Study Selection: Published articles that reported post-PCI FFR after DES implantation and its association with clinical outcomes were included. Data Extraction and Synthesis: Patient-level data were collected from the corresponding authors of 17 cohorts using a standardized spreadsheet. Meta-estimates for primary and secondary outcomes were analyzed per patient and using mixed-effects Cox proportional hazard regression with registry identifiers included as a random effect. All processes followed the Preferred Reporting Items for Systematic Review and Meta-analysis of Individual Participant Data. Main Outcomes and Measures: The primary outcome was target vessel failure (TVF) at 2 years, a composite of cardiac death, target vessel myocardial infarction (TVMI), and target vessel revascularization (TVR). The secondary outcome was a composite of cardiac death or TVMI at 2 years. Results: Of 2268 articles identified, 29 studies met selection criteria. Of these, 28 articles from 17 cohorts provided data, including a total of 5277 patients with 5869 vessels who underwent FFR measurement after DES implantation. Mean (SD) age was 64.4 (10.1) years and 4141 patients (78.5%) were men. Median (IQR) post-PCI FFR was 0.89 (0.84-0.94) and 690 vessels (11.8%) had a post-PCI FFR of 0.80 or below. The cumulative incidence of TVF was 340 patients (7.2%), with cardiac death or TVMI occurring in 111 patients (2.4%) at 2 years. Lower post-PCI FFR significantly increased the risk of TVF (adjusted hazard ratio [HR] per 0.01 FFR decrease, 1.04; 95% CI, 1.02-1.05; P < .001). The risk of cardiac death or MI also increased inversely with post-PCI FFR (adjusted HR, 1.03; 95% CI, 1.00-1.07, P = .049). These associations were consistent regardless of age, sex, the presence of hypertension or diabetes, and clinical diagnosis. Conclusions and Relevance: Reduced FFR after DES implantation was common and associated with the risks of TVF and of cardiac death or TVMI. These results indicate the prognostic value of post-PCI physiologic assessment after DES implantation.

Indexed as

Drug-Eluting StentsFractional Flow Reserve, MyocardialMyocardial InfarctionPercutaneous Coronary InterventionCoronary AngiographyDeathFemaleHumansMaleMiddle AgedPrognosisTreatment Outcome

Identifiers

PMID36136329
PMCPMC9500557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.